| Date Filed | Type | Description |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2022 |
4
| Norchi Terrence W (PRESIDENT AND CHIEF EXECUTIVE) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 72,435 shares
@ $0
Granted options to buy
@ $0
Granted 482,897 options to buy
@ $0.0497, valued at
$24k
|
|
| 07/08/2022 |
4
| Hicks Laurence (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 108,652 shares
@ $0
Granted 36,000 options to buy
@ $0
Granted 724,346 options to buy
@ $0.0497, valued at
$36k
|
|
| 06/09/2022 |
4
| Yrigoyen Dan (VICE PRESIDENT, SALES) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $0.0605, valued at
$9.1k
|
|
| 01/04/2022 |
4
| Fish Guy L. (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.095, valued at
$23.8k
|
|
| 01/04/2022 |
3
| Fish Guy L. (Director) has filed a Form 3 on Arch Therapeutics, Inc. |
| 10/13/2021 |
4
| Hicks Laurence (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.1028, valued at
$25.7k
|
|
| 10/12/2021 |
3
| Hicks Laurence (Director) has filed a Form 3 on Arch Therapeutics, Inc. |
| 10/01/2021 |
4
| Yrigoyen Dan (Vice President, Sales) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.1028, valued at
$20.6k
|
|
| 10/01/2021 |
4
| ABRAMS MICHAEL S (CFO) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $0.1028, valued at
$36k
|
|
| 10/01/2021 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.1028, valued at
$25.7k
|
|
| 10/01/2021 |
4
| DHILLON PUNIT (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.1028, valued at
$25.7k
|
|
| 10/01/2021 |
4
| Norchi Terrence W (President, CEO and Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.1028, valued at
$102.8k
|
|
| 08/11/2021 |
4
| Yrigoyen Dan (Vice President, Sales) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Granted 150,000 options to buy
@ $0.09, valued at
$13.5k
|
|
| 08/11/2021 |
3
| Yrigoyen Dan (Vice President, Sales) has filed a Form 3 on Arch Therapeutics, Inc. |
| 05/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2019 |
4
| Norchi Terrence W (President & CEO) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.2292, valued at
$229.2k
|
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2018 |
4/A
| DHILLON AVTAR S (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 220,000 options to buy
@ $0.425, valued at
$93.5k
|
|
| 07/20/2018 |
4
| SULAT JAMES R (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 110,000 shares
@ $0
Granted 110,000 options to buy
@ $0.425, valued at
$46.8k
|
|
| 07/20/2018 |
4
| Norchi Terrence W (President & CEO) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 360,000 shares
@ $0
Granted 360,000 options to buy
@ $0.425, valued at
$153k
|
|
| 07/20/2018 |
4
| DAVIS RICHARD E (CFO & Treasurer) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 275,000 shares
@ $0
Granted 275,000 options to buy
@ $0.425, valued at
$116.9k
|
|
| 07/20/2018 |
4
| DHILLON PUNIT (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $0.425, valued at
$85k
|
|
| 07/20/2018 |
4
| DHILLON AVTAR S (Director) has filed a Form 4 on Arch Therapeutics, Inc.|
Txns:
| Granted 220,000 shares
@ $0
Granted 220,000 options to buy
@ $0.425, valued at
$93.5k
|
|
| 07/20/2018 |
3
| DHILLON PUNIT (Director) has filed a Form 3 on Arch Therapeutics, Inc. |
|